China National Accord Medicines Corp Ltd (000028) — Cash Flow Quality Index
China National Accord Medicines Corp Ltd (000028) has a Cash Flow Quality Index of -1.46x as of September 2025. Operating cash flow of CN¥-425.23 Million is below net income of CN¥291.21 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 000028 cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
China National Accord Medicines Corp Ltd Cash Flow Quality Index (1998–2024)
Historical Cash Flow Quality Index for China National Accord Medicines Corp Ltd across 26 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check China National Accord Medicines Corp Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for China National Accord Medicines Corp Ltd (1998–2024)
Year-by-year earnings quality comparison for China National Accord Medicines Corp Ltd. For live market cap and the full company financial profile, see 000028 stock market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 13.80x | CN¥3.27 Billion | CN¥237.00 Million | ▲ +651.6% |
| 2023 | 1.84x | CN¥2.94 Billion | CN¥1.60 Billion | ▲ +27.1% |
| 2022 | 1.45x | CN¥2.56 Billion | CN¥1.77 Billion | ▲ +33.4% |
| 2021 | 1.08x | CN¥1.66 Billion | CN¥1.53 Billion | ▲ +24.1% |
| 2020 | 0.87x | CN¥1.50 Billion | CN¥1.72 Billion | ▼ -35.2% |
| 2019 | 1.35x | CN¥2.00 Billion | CN¥1.48 Billion | ▲ +37.4% |
| 2018 | 0.98x | CN¥1.32 Billion | CN¥1.35 Billion | ▼ -11.7% |
| 2017 | 1.11x | CN¥1.29 Billion | CN¥1.16 Billion | ▼ -3.3% |
| 2016 | 1.15x | CN¥1.47 Billion | CN¥1.28 Billion | ▼ -13.7% |
| 2015 | 1.33x | CN¥1.05 Billion | CN¥787.35 Million | ▲ +211.9% |
| 2014 | -1.19x | CN¥-796.70 Million | CN¥669.84 Million | ▼ -236.6% |
| 2013 | 0.87x | CN¥465.03 Million | CN¥534.22 Million | ▲ +30.0% |
| 2012 | 0.67x | CN¥323.96 Million | CN¥483.68 Million | ▼ -3.4% |
| 2011 | 0.69x | CN¥227.32 Million | CN¥327.82 Million | ▼ -57.2% |
| 2010 | 1.62x | CN¥428.16 Million | CN¥264.22 Million | ▲ +18.6% |
| 2009 | 1.37x | CN¥270.85 Million | CN¥198.26 Million | ▼ -10.0% |
| 2008 | 1.52x | CN¥246.58 Million | CN¥162.45 Million | ▲ +116.2% |
| 2007 | 0.70x | CN¥87.70 Million | CN¥124.91 Million | ▼ -70.0% |
| 2006 | 2.34x | CN¥181.73 Million | CN¥77.76 Million | ▼ -43.6% |
| 2005 | 4.15x | CN¥148.28 Million | CN¥35.77 Million | ▼ -15.4% |
| 2004 | 4.90x | CN¥130.30 Million | CN¥26.58 Million | ▼ -8.9% |
| 2003 | 5.38x | CN¥81.22 Million | CN¥15.11 Million | ▼ -20.1% |
| 2002 | 6.73x | CN¥28.76 Million | CN¥4.28 Million | ▲ +227.3% |
| 2001 | 2.06x | CN¥71.16 Million | CN¥34.61 Million | ▲ +130.7% |
| 1999 | 0.89x | CN¥22.84 Million | CN¥25.62 Million | ▲ +141.6% |
| 1998 | 0.37x | CN¥5.21 Million | CN¥14.12 Million | — |